IBM Watson Health, OrbitalRX Launches Solution to Combat U.S. Drug Shortage

What You Ought to Know:

IBM Watson
Health and OrbitalRX revealed a.
tactical partnership that intends to assist address the emerging U.S. drug.
scarcity crisis. The companies are combining OrbitalRXs Drug Shortage.
Management Platform and IBM ® Micromedex ® into one combined service.
called “OrbitalRX.
and Micromedex,” developed to create a single source for healthcare.
suppliers and pharmacy teams to gain access to evidence-based treatment info.
alongside a health centers existing drug stock status and drug sourcing alternatives.
This one option intends to quickly analyze the supply chain and determine.
medical alternatives for drugs that are in short supply.

— Joint using sets drug store supply chain management
capabilities with evidence-based drug material, developed to help hospital pharmacy
teams manage drug lacks.

OrbitalRX and Micromedex is prepared for to be available.
in Q4 2020..

< " Hospital resources are scarcer than ever, specifically with drug shortages and supply chain ineffectiveness conspiring day-to-day to overthrow the strenuous efforts of health systems to enhance care quality while decreasing cost," stated OrbitalRX co-founder and Chief Product Officer, Nate Peaty, PharmD, MS. "With these challenges in mind, OrbitalRX and Micromedex plan to provide health systems with a automatic and extremely intelligent service developed to help them with one of the most aggravating concerns they face today.". The international drug lack crisis has sped up at an. disconcerting rate throughout the COVID-19 crisis. According to the American. Society of Health-Systems Pharmacists ( ASHP), close to 200 drugs are. currently on the drug scarcity list in the U.S. alone. Management of these. lacks is further complicated by the reality that scarcities differ by drug and. location, as kept in mind by the American. Medical Association ( AMA). COVID-19 Underscores Global Drug Shortage. Accessibility. IBM Micromedex is among the biggest online referral databases for medication information. It is used by more than 4,500 healthcare facilities and health systems worldwide to help support decision-making in medication therapy management, condition and illness management, toxicology, natural medicine, and patient education. OrbitalRX is the only platform created by health center pharmacists, for medical facility pharmacists, to unify supply chain and scientific utilization to handle drug shortages and deliver the power of real-time situational awareness in medical facility pharmacy workflows. -- OrbitalRX with Micromedex will produce a single source for doctor and pharmacists to access the most recent evidence-based scientific details alongside a healthcare facilitys current drug inventory status and drug sourcing options. -- IBM Watson Health and OrbitalRX launches an integrated solution to help health center pharmacy providers in handling drug shortages. The brand-new solution, OrbitalRX, and Micromedex, will be designed to evaluate crucial drug info, medical evidence, and relative efficacy, together with the hospitals drug stock, purchase history, and usage information, making it possible for hospital providers, pharmacists, and drug store service technicians to proactively handle drug lacks.